Clinical trial
Quantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in…
NCT00393341 · Indiana University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00393341 |
|---|---|
| Title | Quantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast Cancer |
| Official title | Quantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast Cancer |
| Acronym | EPC |
| Lead sponsor | Indiana University School of Medicine, Other |
| Collaborators | Breast Cancer Research Foundation |
| Status | Completed |
| Study type | Observational |
| Conditions | Breast Cancer Stage IV, Breast Cancer Stage I, Breast Cancer Stage II |
| Intervention type | Procedure |
| Interventions | Blood Draw |
| Enrollment | 68 |
| Start date | Oct 1, 2006 |
| Primary completion | May 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Oct 27, 2006 |
| Last update posted | Aug 31, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: